用户名: 密码: 验证码:
单卵裂球建立小鼠胚胎干细胞系的研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
胚胎干细胞(Embryionic stem cell,ES细胞)在自然状态下并不存在,通常从囊胚内细胞团(ICM)分离得到,与ICM细胞一样ES细胞具有暂时性的自我更新和多种分化潜能的性质。ES细胞是具有分化为外胚层、中胚层和内胚层组织细胞能力的干细胞,是研究细胞“干性”和早期胚胎发育的良好模型,因此广泛地应用于发育生物学、细胞生物学、分子生物学和医学等研究领域。
     ES细胞被认为是细胞组织移植治疗最有潜能的细胞资源。但是传统分离ES细胞的方法引发了伦理方面的问题。最近报道表明可以从着床前小鼠胚胎单卵裂球成功建立ES细胞系,这一突破性进展在一定程度上解决了自体ES细胞临床应用面临的伦理冲突。因此,人们对采用单卵裂球分离自身ES细胞的方法产生了浓厚的兴趣。但是,该方法尚不成熟仍然存在很多问题,如单卵裂球建立ES细胞的成功率相对很低;姐妹卵裂球是否都具有相同的衍生成ES细胞的能力;它们是否有不同的发育命运等等。因此,对单裂球分离ES细胞系进行更为深入的研究,建立适合的培养体系,提高ES细胞的分离效率,对ES细胞临床应用至关重要。
     本研究以小鼠为模型,深入研究单个卵裂球建立小鼠ES细胞系,优化了培养体系。研究中首先利用MTT法对丝裂霉素C处理后MEF活力变化进行检测。结果显示,第1,3,5代的MEF,丝裂霉素C(10μg/mL)处理2或3hr,其形态良好,活力可稳定维持是制备饲养层较为理想的条件。
     在MEF共培养体系下,比较了KSOM和mES两种培养液对ES细胞建立的影响,表明KSOM+mES连续培养体系更有利于ICM的形成,且不改变Cdx2阳性细胞(TE)和Sox-2阳性细胞(ICM)之间比率。MEF共培养下采用KSOM及mES连续培养方案,共建立了71个可传至5代以上的ES样细胞系。其中2CBD获得29个ES样细胞系(72.5%),4CBD和8CBD建系率较低分别为30.0%和11.3%。胚胎的发育阶段越高级从单卵裂球建立ES细胞系的成功率越低。此外,本研究通过对干细胞标志分子表达方式和ICM的形成以及ES细胞分离等方面的研究,证明2-细胞,4-细胞和8-细胞胚胎的姐妹卵裂球并不均一,具有不同的发育能力。由于早期胚胎中的分化决定导致了姐妹卵裂球之间多能性的不平等,很可能是导致胚胎单卵裂球建立ES细胞效率较低的原因。
     此外,本研究中采用MEF共培养体系,大胆比较LIF添加与否对单卵裂球建立ES细胞系的影响。结果表明不论LIF添加与否,2CBD,4CBD和8CBD都可以形成初级扩展生长。尽管胚胎发育率相似,2CBD-LIF和2CBD-control组分别以83.8%和70.0%的比例建立初级扩展生长。可见,饲养层细胞的存在对ES细胞的建立和维持比培养液中添加LIF更为重要。在MEF共培养体系中LIF的添加与否对于建立ES样细胞克隆不是必要条件,而且ES细胞可在不添加LIF的共培养体系中维持自我更新。有趣的是LIF和MEK1/2抑制剂PD98059协作有助于ES细胞的自我更新,在LIF作用下,激活gp130,同时抑制MEK/ERK通路,对于维持ES细胞的自我更新和分化之间的平衡具有重要作用,只有二者之间保持精确的平衡,ES细胞的自我更新才能保证。研究结果表明,PD98059的靶基因ERK1/2可能参与2-细胞阶段母源基因向胚胎基因的转换(MET)并且激活合子基因组。经ES细胞鉴定,结果表明大部分ES样细胞系保持正常的核型并表达多能性的标志分子,可以在嵌合体小鼠中进行生殖系传递。因此从早期胚胎单个卵裂球建立ES细胞系是可行的。随机抽取早期胚胎的单卵裂球,不经任何特殊处理就具有建立ES细胞的潜能。单卵裂球建立ES细胞的成功率与胚胎发育阶段负相关。
Embryonic stem (ES) cells which do not exist in nature, usually can be derived from the inner cell mass (ICM) of the blastocyst, are considered equivalent to ICM cells possessing self-renewal and pluripotency capability. ES cells are the only stem cell type able to possess indefinite self-renewal and to differentiate into cellular derivates of ectodermal, mesodermal and endodermal lineages and are formidable models to investigate fundamental aspects of cell stemness and early embryo development. Therefore they are widely used in the areas of Development Biology, Cell Biology, Molecular Biology and Medical Research and so on..
     ES cell line has been considered as the most potential cell source of cell tissue therapies. But the traditional method of establishment ES cell line is surrounding by many ethical concerns. Recently success in establishing mouse ES cell lines from a single blastomere of preimplantation embryos has led to a new development in stem cell technology. To some extent this breakthrough demonstrates the possibility of personalized ES cells that would eliminate the ethical concerns surrounding therapeutic cloning. As a result, there was a strong interest in a single blastomere derived ES cells for clinical application of deriving personalized ES cells. However, a relatively low success rate in establishing ES cells from a single blastomere and whether all sister blastomeres are equally competent in deriving ES cells, or if they have distinct fate, these issues indicated that the method itself is immaturation and has many problems need to be discovered. Therefore it is crucial for ES cell clinical application to further investigate a single blastomere deriving ES cell; optimize culture system and enhance success rate in establishing ES cells from a single blastomere.
     The objective of this study was to optimize the condition of establishing embryonic stem cell from a single blastomere of embryo by using mice as animal models. First the study analyzed cell viability and maintence time of MEF after treatment of mitomycin C by means of MTT method, compared effects of treating time of mitomycin C and cell passages on MEF viabilities after mitomycin C treatment. The results suggest that cell viability sustains more stable after 2 hours and 3 hours of mitomycin C treatment at the concentration of 10μg/mL. Meanwhile, MEF vitalities at the first, the third and the fifth passage were proved to be the suitable condition in preparation for MEF feeder layers.
     Under the MEF co-culture system we compared the effect of KSOM and mES media on the establishment of ES cells. Our results suggested KSOM is better to enhance mouse single blastomere development, blastocyst development, attachment and the establishment of embryonic outgrowth. We had adopted the co-culture system of mouse ES cells and modified with sequential medium. The continuous co-culture system can promote ICM formation without change the ratio of Cdx2 positive cells (TE) and Sox-2 positive cells (ICM). In total, 71 mES-like cell lines which can be subcultured to up 5 passages have been established in KSOM and mES continuous co-culture system. Among them, there is 29 ES-like cell lines are derived from a single blastomere of two-cell embryos (72.5%). The ES-like cell lines establishment efficiency from 4CBD and 8CBD are much lower than 2CBD (30.0% and 11.3% separately).The more advanced stage embryo resulted in the lower success rate in establishing ES cells from single blastomere. According to expression pattern of stem cell markers, the formation of ICM and the derivation of ES cells, we demonstrated that sister blastomeres of two-, four- and eight-cell embryos were not identical and were not equally competent. Those suggest that the low efficiency in ES cells establishment from a single blastomere of embryos was due to the differentiation in early embryos that resulted in unequal pluripotence competent among sister blastomeres.
     We also compared the effect on deriveing ES cell line from a single blastomere of embryo with or without LIF. Our results indicated 2CBD, 4CBD and 8CBD can derive primary outgrowth no matter addition of LIF or not. Though the ratio of embryo development of 2CBD-LIF and 2CBD-control is similarity, the ratio of primary outgrowth of them is 83.8% and 70.0% separately. So the addition of LIF is not necessary for establishing ICM-derived ES cell-like colonies in the presence of fibroblast monolayer, and established ES cells can be maintained in an LIF-free medium. Interestingly, blockade of MEK/ERK activity in combination with increased gp130 signalling might promote the self-renewal of ES cell lines. We investigated the effect of inhibition of MEK/ERK signalling (PD98059) combined with increasing stimulation of gp130 signalling by LIF on derivation of ES cells. The result suggested the cooperation of LIF signal and MEK/ERK signalling is essential to the self-renewal of ES cell. Our finding suggested that ERK1/2 which is a target of PD98059 might involve in maternal embryonic transition (MET) and the activation of zygotic genome at the two-cell stage. Most cell lines maintained normal karyotype and expressed markers of pluripotency, including germline transmission in chimeric mice. Our results suggest that the single cells of all early-stage embryos have the potential to be converted into ES cells without any special treatment. The ES cell lines establishment efficiency from a single blastomere of embryo is inversely proportional to the embryo development stages.
引文
Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo.J Biol Chem. 270(46):27489-27494.
    Allen WR, Pashen RL. 1984. Production of monozygotic (identical) horse twins by embryo micromanipulation. J Reprod Fertil. 71(2):607-613.
    Amabile G, Meissner A. 2009. Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol Med. 15(2):59-68.
    Amano K, Furuno T, Nakanishi M. 2006. Conditioned medium from feeder STO cells increases the attachment of mouse embryonic stem cells. Biol Pharm Bull. 29(8):1747-1750.
    Amit M, Carpenter MK, Inokuma MS, Chiu CP, Harris CP, Waknitz MA, Itskovitz-Eldor J, Thomson JA. 2000. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol. 227(2):271-278.
    Amit M, Margulets V, Segev H, Shariki K, Laevsky I, Coleman R, Itskovitz-Eldor J. 2003.
    Human feeder layers for human embryonic stem cells. Biol Reprod. 68(6):2150-2156.
    Amit M, Shariki C, Margulets V, Itskovitz-Eldor J. 2004. Feeder layer- and serum-free culture of human embryonic stem cells. Biol Reprod. 70(3):837-845.
    Annerén C. 2008. Tyrosine kinase signalling in embryonic stem cells. Clin Sci (Lond). 115(2):43-55.
    Aubert J, Dunstan H, Chambers I, Smith A. 2002. Functional gene screening in embryonic stem cells implicates Wnt antagonism in neural differentiation. Nat Biotechnol. 20(12):1240-1245.
    Avery S, Inniss K, Moore H. 2006.The regulation of self-renewal in human embryonic stem cells. Stem Cells Dev. 15(5):729-740.
    Bagis H, Mercan HO, Sauirkaya H, Turgut G, and Dinnyes A. 2003. The effect of genetic background on the in vitro development of mouse embryos in potassium simplex optimized medium supplemented with amino acid (KSOMAA). Turk J. Vet Anima Sci. 27: 409-415.
    Baharvand H, Ashtiani SK, Taee A, Massumi M, Valojerdi MR, Yazdi PE, Moradi SZ, Farrokhi A. 2006. Generation of new human embryonic stem cell lines with diploid and triploid karyotypes. Dev Growth Differ. 48(2):117-128.
    Barberi T, Klivenyi P, Calingasan NY, Lee H, Kawamata H, Loonam K, Perrier AL, Bruses J, Rubio ME, Topf N, Tabar V, Harrison NL, Beal MF, Moore MA, Studer L. 2003. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotechnol. 21(10):1200-1207.
    Batlle-Morera L, Smith A, Nichols J. 2008. Parameters influencing derivation of embryonicstem cells from murine embryos. Genesis. 46(12):758-767.
    Beattie GM, Lopez AD, Bucay N, Hinton A, Firpo MT, King CC, Hayek A. 2005. Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells. 23(4):489-495.
    Beddington RS, Robertson EJ. 1989. An assessment of the developmental potential of embryonic stem cells in the midgestation mouse embryo. Development. 105(4):733-777.
    Bendall SC, Stewart MH, Menendez P, George D, Vijayaragavan K, Werbowetski-Ogilvie T, Ramos-Mejia V, Rouleau A, Yang J, BosséM, Lajoie G, Bhatia M. 2007. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature. 30;448(7157):1015-1021.
    Binas B. 2009. Embryo-derived stem cells--a system is emerging. BMB Rep. 42(2):72-80.
    Binétruy B, Heasley L, Bost F, Caron L, Aouadi M. 2007. Concise review: regulation of embryonic stem cell lineage commitment by mitogen-activated protein kinases. Stem Cells. 25(5):1090-1095.
    Biswas A, Hutchins R. 2007. Embryonic stem cells. Stem Cells Dev. 16(2):213-222.
    Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science. 279(5349):349-352.
    Boiani M, Sch?ler HR. 2005. Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol. 6(11):872-884.
    Bongso A, Fong CY, Ng SC, Ratnam S. 1994. Isolation and culture of inner cell mass cells from human blastocysts. Hum Reprod. 9(11):2110-21107.
    Bongso A, Richards M. 2004. History and perspective of stem cell research. Best Pract Res Clin Obstet Gynaecol. 18(6):827-842.
    Bongso A, Tan S. 2005 Human blastocyst culture and derivation of embryonic stem cell lines. Stem Cell Rev. 1(2):87-98.
    Bradley A, Evans M, Kaufman MH, Robertson E. 1984 Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature. 309(5965):255-256.
    Brenin D, Look J, Bader M, Hubner N, Levan G, and Iannaccone P. 1997. Rat embryonic stem cells: a progress report. Transplant Proc 29: 1761–1765.
    Brinster RL, 1974.The effect of cells transferred into the mouse blastocyst on subsequent development. J Exp Med. 1;140(4):1049-1056.
    Brivanlou AH, Gage FH, Jaenisch R, Jessell T, Melton D, Rossant J. 2003. Stem cells. Setting standards for human embryonic stem cells. Science. 300(5621):913-916.
    Brook FA, Gardner RL. 1997. The origin and efficient derivation of embryonic stem cells in the mouse. Proc Natl Acad Sci U S A. 94(11):5709-5712.
    Bryja V, Bonilla S, Cajánek L, Parish CL, Schwartz CM, Luo Y, Rao MS, Arenas E. 2006. An efficient method for the derivation of mouse embryonic stem cells. Stem Cells. 24(4):844-849.
    Buehr M, Meek S, Blair K, Yang J, Ure J, Silva J, McLay R, Hall J, Ying QL, Smith A. 2008. Capture of authentic embryonic stem cells from rat blastocysts. Cell. 135(7):1287-1298.
    Buehr M, Nichols J, Stenhouse F, Mountford P, Greenhalgh CJ, Kantachuvesiri S, Brooker G, Mullins J, and Smith AG. 2003. Rapid loss of Oct-4 and pluripotency in cultured rodent blastocysts and derivative cell lines. Biol Reprod 68: 222-229.
    Buehr M, Smith A. 2003. Genesis of embryonic stem cells. Philos Trans R Soc Lond B Biol Sci. 358(1436):1397-1402.
    Buhr N, Carapito C, Schaeffer C, Hovasse A, Van Dorsselaer A, Viville S. 2007. Proteome analysis of the culture environment supporting undifferentiated mouse embryonic stem and germ cell growth. Electrophoresis. 28(10):1615-1623.
    Burdon T, Smith A, Savatier P. 2002. Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol. 12(9):432-438.
    Burdon T, Stracey C, Chambers I, Nichols J, Smith A. 1999. Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev Biol. 210(1):30-43.
    Cadigan KM, Nusse R. 1997. Wnt signaling: a common theme in animal development. Genes Dev. 11(24):3286-3305.
    Carpenter MK, Rosler E, Rao MS. 2003. Characterization and differentiation of human embryonic stem cells. Cloning Stem Cells. 5(1):79-88.
    Carpenter MK, Rosler ES, Fisk GJ, Brandenberger R, Ares X, Miura T, Lucero M, Rao MS. 2004. Properties of four human embryonic stem cell lines maintained in a feeder-free culture system. Dev Dyn. 229(2):243-258.
    Cartwright P, McLean C, Sheppard A, Rivett D, Jones K, Dalton S. 2005. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development. 132(5):885-896.
    Cavaleri F, Sch?ler HR. 2003. Nanog: a new recruit to the embryonic stem cell orchestra. Cell. 113(5):551-552.
    Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A. 2003. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell. 30;113(5):643-655.
    Chambers I, Smith A. 2004. Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene. 20;23(43):7150-160.
    Chan AW, Dominko T, Luetjens CM, Neuber E, Martinovich C, Hewitson L, Simerly CR, Schatten GP. 2000 Clonal propagation of primate offspring by embryo splitting. Science., 14;287(5451):317-319.
    Chang IK, Jeong DK, Hong YH, Park TS, Moon YK, Ohno T, Han JY. 1997. Production of germline chimeric chickens by transfer of cultured primordial germ cells. Cell Biol Int 21: 495-499.
    Chen LR, Shiue YL, Bertolini L, Medrano JF, BonDurant RH, Anderson GB. 1999. Establishment of pluripotent cell lines from porcine preimplantation embryos. Theriogenology.15;52(2):195-212.
    Chen Y, Li X, Eswarakumar VP, Seger R, Lonai P. 2000. Fibroblast growth factor (FGF) signaling through PI 3-kinase and Akt/PKB is required for embryoid body differentiation. Oncogene. 3;19(33):3750-3756.
    Cho M, Jang M, Lee EJ, Han JY, Lim JM. 2006. An alternative method of deriving embryonic stem cell-like clones by aggregation of diploid cells with tetraploid embryos. Fertil Steril. 85 Suppl 1:1103-1110.
    Chojnacki A, Shimazaki T, Gregg C, Weinmaster G, Weiss S. 2003. Glycoprotein 130 signaling regulates Notch1 expression and activation in the self-renewal of mammalian forebrain neural stem cells. J Neurosci. 23(5):1730-1741.
    Chung Y, Klimanskaya I, Becker S, Marh J, Lu SJ, Johnson J, Meisner L, Lanza R. 2006. Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres. Nature. 439(7073):216-219.
    Coucouvanis E, Martin GR. 1995. Signals for death and survival: a two-step mechanism for cavitation in the vertebrate embryo. Cell. 83(2):279-287.
    Cowan CA, Klimanskaya I, McMahon J, Atienza J, Witmyer J, Zucker JP, Wang S, Morton CC, McMahon AP, Powers D, Melton DA. 2004 Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med. 350(13):1353-1356.
    Dahéron L, Opitz SL, Zaehres H, Lensch MW, Andrews PW, Itskovitz-Eldor J, Daley GQ. 2004 LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells. 22(5):770-778.
    Dang SM, Gerecht-Nir S, Chen J, Itskovitz-Eldor J, Zandstra PW. 2004. Controlled, scalable embryonic stem cell differentiation culture. Stem Cells. 22(3):275-282.
    Dani C. Embryonic stem cell-derived adipogenesis. Cells Tissues Organs. 1999, 165(3-4):173-180.
    Daoud G, Amyot M, Rassart E, Masse A, Simoneau L, Lafond J. 2005. ERK1/2 and p38
    regulate trophoblasts differentiation in human term placenta. J Physiol. 566(Pt 2):409-423.
    De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, Furth ME, Soker S, Atala A. 2007. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 25(1):100-106.
    De Felici M, Farini D, Dolci S. 2009. In or out stemness: comparing growth factor signalling in mouse embryonic stem cells and primordial germ cells. Curr Stem Cell Res Ther. 4(2):87-97.
    Deb K, Sivaguru M, Yong HY, Roberts RM. 2006. Cdx2 gene expression and trophectoderm lineage specification in mouse embryos. Science. 311(5763):992-996.
    Delhaise F, Bralion V, Schuurbiers N, Dessy F. 1996. Establishment of an embryonic stem cell line from 8-cell stage mouse embryos. Eur J Morphol. 34(4):237-243.
    Doetschman T, Williams P, and Maeda N. 1988. Establishment of hamster blastocyst-derived embryonic stem (ES) cells. Dev Biol 127: 224-227.
    Donovan PJ, de Miguel MP. 2003. Turning germ cells into stem cells. Curr. Opin. Genet. Dev. 13, 463-471.
    Du Z, Cong H, Yao, Z. 2001. Identification of putative downstream genes of Oct-4 by suppression-subtractive hybridization. Biochem. Biophys. Res. Commun. 282, 701-706 .
    Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A. 92(17):7686-7689.
    Dvorák P, Hampl A, JirmanováL, PacholíkováJ, Kusakabe M. 1998. Embryoglycan ectodomains regulate biological activity of FGF-2 to embryonic stem cells. J Cell Sci. 111:2945-2952.
    Eiges R, Schuldiner M, Drukker M, Yanuka O, Itskovitz-Eldor J, Benvenisty N. 2001. Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Curr Biol. 11(7):514-518.
    Eisenmann DM. 2005. Wnt signaling. WormBook. 25:1-17.
    Eistetter HR. 1989. Pluripotent embryonal stem cells can be established from disaggregated mouse morulae. Develop. Growth Differ. 31:275-282.
    Evans M, Hunter S. 2002. Source and nature of embryonic stem cells. C R Biol. 325(10):1003-1007.
    Evans MJ, Kaufman MH. 1981. Establishment in culture of pluripotential cells from mouse embryos. Nature. 292(5819):154-156.
    Fujimori T, Kurotaki Y, Miyazaki J, Nabeshima Y. 2003. Analysis of cell lineage in two- and four-cell mouse embryos. Development. 130(21):5113-5122.
    Furue M, Okamoto T, Hayashi Y, Okochi H, Fujimoto M, Myoishi Y, Abe T, Ohnuma K, Sato GH, Asashima M, Sato JD. 2005. Leukemia inhibitory factor as an anti-apoptotic mitogen for pluripotent mouse embryonic stem cells in a serum-free medium without feeder cells. In Vitro Cell Dev Biol Anim. 41(1-2):19-28.
    Gallagher EJ, Lodge P, Ansell R, McWhir J. 2003. Isolation of murine embryonic stem and embryonic germ cells by selective ablation. Transgenic Res. 12(4):451-460.
    Gardner RL, Brook FA. Reflections on the biology of embryonic stem (ES) cells. 1997. Int J Dev Biol. 41(2):235-243.
    Gardner RL. 1983. Origin and differentiation of extraembryonic tissues in the mouse. Int Rev Exp Pathol. 24:63-133.
    Gardner RL. 2001. Specification of embryonic axes begins before cleavage in normal mouse development. Development. 128(6):839-847.
    Geijsen N, Horoschak M, Kim K, Gribnau J, Eggan K, Daley GQ. 2004. Derivation of embryonic germ cells and male gametes from embryonic stem cells. Nature. 427(6970):148-154.
    Genbacev O, Krtolica A, Zdravkovic T, Brunette E, Powell S, Nath A, Caceres E, McMaster M, McDonagh S, Li Y, Mandalam R, Lebkowski J, Fisher SJ. 2005. Serum-free derivation of human embryonic stem cell lines on human placental fibroblast feeders. Fertil Steril.83(5):1517-1529.
    Graves KH, Moreadith RW. 1993. Derivation and characterization of putative pluripotential embryonic stem cells from preimplantation rabbit embryos. Mol Reprod Dev. 36(4):424-433.
    Hamazaki T, Oka M, Yamanaka S, Terada N. 2004. Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. J Cell Sci. 117:5681-5686.
    Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F. 2003. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J. 374(Pt 1):1-20.
    Heins N, Englund MC, Sj?blom C, Dahl U, Tonning A, Bergh C, Lindahl A, Hanson C, Semb H. 2004. Derivation, characterization, and differentiation of human embryonic stem cells. Stem Cells. 22(3):367-376.
    Hernandez L, Kozlov S, Piras G, and Stewart CL.2003.Paternal and maternal genomes confer opposite effects on proliferation, cellcycle length, senescence, and tumor formation. Proc Natl Acad Sci USA 100: 13344–13349.
    Heyman Y, Vignon X, ChesnéP, Le Bourhis D, Marchal J, Renard JP. 1998. Cloning in cattle: from embryo splitting to somatic nuclear transfer. Reprod Nutr Dev. 38(6):595-603.
    Hiiragi T, Alarcon VB, Fujimori T, Louvet-Vallee S, Maleszewski M, Marikawa Y, Maro B, Solter D. 2006, Where do we stand now? Mouse early embryo patterning meeting in Freiburg, Germany. Int J Dev Biol. 50(7):581-586; discussion 586-587.
    Hombría JC, Brown S. 2002. The fertile field of Drosophila Jak/STAT signalling. Curr Biol. 12(16):R569-575.
    Hübner K, Fuhrmann G, Christenson LK, Kehler J, Reinbold R, De La Fuente R, Wood J, Strauss JF 3rd, Boiani M, Sch?ler HR. 2003, Derivation of oocytes from mouse embryonic stem cells. Science. 23;300(5623):1251-1256.
    Itoh N, Ornitz DM. 2008. Functional evolutionary history of the mouse Fgf gene family. Dev Dyn. 237(1):18-27.
    Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, Amit M, Soreq H, Benvenisty N. 2000. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med. 6(2):88-95.
    Ivanova NB, Dimos JT, Schaniel C, Hackney JA, Moore KA, Lemischka IR. 2002. Science. 298(5593):601-604.
    Jacobson L, Kahan B, Djamali A, Thomson J, Odorico JS. Differentiation of endoderm derivatives, pancreas and intestine, from rhesus embryonic stem cells. Transplant Proc. 2001, 33(1-2):674.
    Johnson WH, Loskutoff NM, Plante Y, Betteridge KJ. 1995. Production of four identical calves by the separation of blastomeres from an in vitro derived four-cell embryo. Vet Rec. 137(1):15-16.
    Kanatsu-Shinohara M, Inoue K, Lee J, Yoshimoto M, Ogonuki N, Miki H, Baba S, Kato T,
    Kazuki Y, Toyokuni S, Toyoshima M, Niwa O, Oshimura M, Heike T, Nakahata T, Ishino F, Ogura A, Shinohara T. 2004. Generation of pluripotent stem cells from neonatal mouse testis. Cell. 119(7):1001-1012.
    Kawasaki H, Suemori H, Mizuseki K, Watanabe K, Urano F, Ichinose H, Haruta M, Takahashi M, Yoshikawa K, Nishikawa SI, Nakatsuji N, and Sasai Y. 2002. Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity. Proc Natl Acad Sci USA 99: 1580–1585.
    Kawase E, Suemori H, Takahashi N, Okazaki K, Hashimoto K, Nakatsuji N. 1994. Strain difference in establishment of mouse embryonic stem (ES) cell lines. Int J Dev Biol. 38(2):385-390.
    Keskintepe L, Norris K, Pacholczyk G, Dederscheck SM, Eroglu A. 2007. Derivation and comparison of C57BL/6 embryonic stem cells to a widely used 129 embryonic stem cell line. Transgenic Res. 16(6):751-758.
    Kim K, Lerou P, Yabuuchi A, Lengerke C, Ng K, West J, Kirby A, Daly MJ, Daley GQ. 2007. Histocompatible embryonic stem cells by parthenogenesis. Science. 315(5811):482-486.
    Klein D, Schmandt T, Muth-K?hne E, Perez-Bouza A, Segschneider M, Gieselmann V, Brüstle O. 2006. Embryonic stem cell-based reduction of central nervous system sulfatide storage in an animal model of metachromatic leukodystrophy. Gene Ther. 13(24):1686-1695.
    Kleinsmith LJ, Pierce GB Jr. 1964. Multipotentiality of single embryonal carcinoma cells. Cancer Res. 24:1544-1551.
    Klimanskaya I, Chung Y, Becker S, Lu SJ, Lanza R. 2006. Human embryonic stem cell lines derived from single blastomeres. Nature. 444(7118):481-485.
    Kondo T, Raff M. 2000. Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. Science. 289(5485):1754-1757.
    Kristensen DM, Kalisz M, Nielsen JH. 2005. Cytokine signalling in embryonic stem cells. APMIS. 113(11-12):756-772.
    Kumar D, Anand T, Singh MK, Chauhan MS, Manik RS. 2009. Characterization of embryonic stem cells: A special focus on farm animals. Indian Journal of Biotechnology. 8 :23-32.
    Kwon OY, Kono T. 1996. Production of identical sextuplet mice by transferring metaphase nuclei from four-cell embryos. Proc Natl Acad Sci U S A. 93(23):13010-13013.
    Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L, Wang X, Finegold M, Weissman IL, Grompe M. 2000. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 6(11):1229-1234.
    Lake J, Rathjen J, Remiszewski J, Rathjen PD. 2000. Reversible programming of pluripotent cell differentiation. J Cell Sci. 113 ( Pt 3):555-566.
    Lee JB, Lee JE, Park JH, Kim SJ, Kim MK, Roh SI, Yoon HS. 2005. Establishment and maintenance of human embryonic stem cell lines on human feeder cells derived from uterine endometrium under serum-free condition. Biol Reprod. 72(1):42-49.
    Lee JB, Song JM, Lee JE, Park JH, Kim SJ, Kang SM, Kwon JN, Kim MK, Roh SI, Yoon HS.2004. Available human feeder cells for the maintenance of human embryonic stem cells. Reproduction. 128(6):727-735.
    Lee JH, Lee EJ, Lee CH, Park JH, Han JY, Lim JM. 2009. Requirement of leukemia inhibitory factor for establishing and maintaining embryonic stem cells in mice. Fertil Steril. 92(3):1133-1140.
    Lee SH, Lumelsky N, Studer L, Auerbach JM, McKay RD. 2000. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol. 18(6):675-679.
    Li J, Wang G, Wang C, Zhao Y, Zhang H, Tan Z, Song Z, Ding M, Deng H. 2007. MEK/ERK signaling contributes to the maintenance of human embryonic stem cell self-renewal. Differentiation. 75(4):299-307.
    Li M, Li YH, Hou Y, Sun XF, Sun Q, Wang WH. 2004. Isolation and culture of pluripotent cells from in vitro produced porcine embryos. Zygote. 12(1):43-48.
    Li M, Zhang D, Hou Y, Jiao L, Zheng X, Wang WH. 2003. Isolation and culture of embryonic stem cells from porcine blastocysts. Mol Reprod Dev. 65(4):429-434.
    Lodge P, McWhir J, Gallagher E, Sang H. 2005. Increased gp130 signaling in combination with inhibition of the MEK/ERK pathway facilitates embryonic stem cell isolation from normally refractory murine CBA blastocysts. Cloning Stem Cells. 7(1):2-7.
    Lorthongpanich C, Yang SH, Piotrowska-Nitsche K, Parnpai R, Chan AW. 2008. Chemical enhancement in embryo development and stem cell derivation from single blastomeres. Cloning Stem Cells. 10(4):503-512.
    Lorthongpanich C, Yang SH, Piotrowska-Nitsche K, Parnpai R, Chan AW. 2008. Development of single mouse blastomeres into blastocysts, outgrowths and the establishment of embryonic stem cells. Reproduction. 135(6):805-813.
    Ludwig TE, Levenstein ME, Jones JM, Berggren WT, Mitchen ER, Frane JL, Crandall LJ, Daigh CA, Conard KR, Piekarczyk MS, Llanas RA, Thomson JA. 2006. Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol. 24(2):185-187.
    Madan P, Calder MD, Watson AJ. 2005, Mitogen-activated protein kinase (MAPK) blockade of bovine preimplantation embryogenesis requires inhibition of both p38 and extracellular signal-regulated kinase (ERK) pathways. Reproduction. 130(1):41-51.
    Maekawa M, Yamamoto T, Tanoue T, Yuasa Y, Chisaka O, Nishida E. 2005. Requirement of the MAP kinase signaling pathways for mouse preimplantation development. Development. 132(8):1773-1783.
    Martin GR, Evans MJ. 1975. Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro. Proc Natl Acad Sci U S A. 72(4):1441-1445.
    Martin GR. 1981. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A. 78(12):7634-7638.
    Mateizel I, De Temmerman N, Ullmann U, Cauffman G, Sermon K, Van de Velde H, De Rycke M, Degreef E, Devroey P, Liebaers I, Van Steirteghem A. 2006. Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders.Hum Reprod. 21(2):503-511.
    Matsuda T, Nakamura T, Nakao K, Arai T, Katsuki M, Heike T, Yokota T. 1999. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J. 18(15):4261-4269.
    Matsumoto K, Miyake M, Utsumi K, Iritani A. 1989. Production of identical twins by separating two-cell rat embryos. Gamete Res. 22(3):257-263.
    McDonald FJ, Heath JK. 1994, Developmentally regulated expression of fibroblast growth factor receptor genes and splice variants by murine embryonic stem and embryonal carcinoma cells. Dev Genet. 15(2):148-154.
    Meng GL, Zur Nieden NI, Liu SY, Cormier JT, Kallos MS, Rancourt DE. 2008. Properties of murine embryonic stem cells maintained on human foreskin fibroblasts without LIF. Mol Reprod Dev. 75(4):614-622.
    Mitalipov S, Kuo HC, Byrne J, Clepper L, Meisner L, Johnson J, Zeier R, Wolf D. 2006. Isolation and characterization of novel rhesus monkey embryonic stem cell lines. Stem Cells. 24(10):2177-2186.
    Mitalipov SM, Yeoman RR, Kuo HC, Wolf DP. 2002. Monozygotic twinning in rhesus monkeys by manipulation of in vitro-derived embryos. Biol Reprod. 66(5):1449-1455.
    Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, Yamanaka S. 2003. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell. 113(5):631-642.
    Miyabayashi T, Teo JL, Yamamoto M, McMillan M, Nguyen C, Kahn M. 2007. Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency. Proc Natl Acad Sci U S A. 104(13):5668-5673.
    Miyamoto K, Hayashi K, Suzuki T, Ichihara S, Yamada T, Kano Y, Yamabe T, Ito Y. 2004. Human placenta feeder layers support undifferentiated growth of primate embryonic stem cells. Stem Cells. 22(4):433-440.
    Mu?oz M, Trigal B, Molina I, Díez C, Caama?o JN, Gómez E. 2009. Constraints to progress in embryonic stem cells from domestic species. Stem Cell Rev. 5(1):6-9.
    Munsie MJ, Michalska AE, O'Brien CM, Trounson AO, Pera MF, Mountford PS. 2000. Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei. Curr Biol. 24;10(16):989-992.
    Nagy A, Derivation of new ES cell lines (Andras Nagy Lab) [On-line]. Available: www.mshri.on.ca/cores/ESfacility/EScDer2005.pdf.
    Nagy A, Gertsenstein M, Vintersten K, Behringer R, 2003. Manipulating the Mouse Embryo, 3rd ed., , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, USA.
    Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC. 1993. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A. 15;90(18):8424-8428.
    Natale DR, Paliga AJ, Beier F, D'Souza SJ, Watson AJ. 2004. p38 MAPK signaling during murine preimplantation development. Dev Biol. 268(1):76-88.
    Nichols J, Chambers I, Smith A. 1994. Derivation of germline competent embryonic stem cells with a combination of interleukin-6 and soluble interleukin-6 receptor. Exp Cell Res. 215(1):237-239.
    Nichols J, Chambers I, Taga T, Smith A. 2001. Physiological rationale for responsiveness of mouse embryonic stem cells to gp130 cytokines. Development. 128(12):2333-2339.
    Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Sch?ler H, Smith A. 1998. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell. 95(3):379-391.
    Niwa H, Burdon T, Chambers I, Smith A. 1998. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 12(13):2048-2060.
    Niwa H, Miyazaki J, Smith AG. 2000. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nature Genet. 24, 372–376.
    Niwa H. 2000. Molecular mechanism for cell-fate determination in ES cells Tanpakushitsu Kakusan Koso. 45(13 Suppl):2047-2055.
    Okita K, Yamanaka S. 2006. Intracellular signaling pathways regulating pluripotency of embryonic stem cells. Curr Stem Cell Res Ther. 1(1):103-111.
    Ozil JP. 1983. Production of identical twins by bisection of blastocysts in the cow. J Reprod Fertil. 69(2):463-468.
    Pain B, Clark ME, Shen M, Nakazawa H, Sakurai M, Samarut J, Etches RJ. 1996. Long-term in vitro culture and characterisation of avian embryonic stem cells with multiple morphogenetic potentialities. Development 122: 2339–2348.
    Paliga AJ, Natale DR, Watson AJ. 2005. p38 mitogen-activated protein kinase (MAPK) first regulates filamentous actin at the 8-16-cell stage during preimplantation development. Biol Cell. 97(8):629-640.
    Paling NR, Wheadon H, Bone HK, Welham MJ. 2004. Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling. J Biol Chem. 12;279(46):48063-48070.
    Papaioannou VE, Mkandawire J, Biggers JD. 1989. Development and phenotypic variability of genetically identical half mouse embryos. Development. 106(4):817-827.
    Paratore C, and Sommer L. 2006. Cell Signaling and Growth Factors in Development: From Molecules to Organogenesis Klaus Unsicker (Editor), Kerstin Krieglstein (Editor) ISBN: 978-3-527-31034-0 Hardcover. February,1-37.
    Park JH, Kim SJ, Oh EJ, Moon SY, Roh SI, Kim CG, Yoon HS. 2003. Establishment and maintenance of human embryonic stem cells on STO, a permanently growing cell line. Biol Reprod. 69(6):2007-2014.
    Park SP, Lee YJ, Lee KS, Ah Shin H, Cho HY, Chung KS, Kim EY, Lim JH. 2004.
    Establishment of human embryonic stem cell lines from frozen-thawed blastocysts using STO cell feeder layers. Hum Reprod. 19(3):676-684.
    Pau KY, Wolf DP. 2004. Derivation and characterization of monkey embryonic stem cells. Reprod Biol Endocrinol 2: 41.
    Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH. 2001. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2(2):153-183.
    Pelton TA, Sharma S, Schulz TC, Rathjen J, Rathjen PD. 2002. Transient pluripotent cell populations during primitive ectoderm formation: correlation of in vivo and in vitro pluripotent cell development. J Cell Sci. 115(Pt 2):329-339.
    Pera MF, Trounson AO. 2004. Human embryonic stem cells: prospects for development. Development. 131(22):5515-5525.
    Piotrowska K, Wianny F, Pedersen RA, Zernicka-Goetz M. 2001. Blastomeres arising from the first cleavage division have distinguishable fates in normal mouse development. Development. 128(19):3739-3748.
    Piotrowska-Nitsche K, Perea-Gomez A, Haraguchi S, Zernicka-Goetz M. 2005. Four-cell stage mouse blastomeres have different developmental properties. Development. 132(3):479-490.
    Plusa B, Hadjantonakis AK, Gray D, Piotrowska-Nitsche K, Jedrusik A, Papaioannou VE, Glover DM, Zernicka-Goetz M. 2005. The first cleavage of the mouse zygote predicts the blastocyst axis. Nature. 434(7031):391-395.
    Polejaeva IA, Reed WA, Bunch TD, Ellis LC, White KL. 1997. Prolactin-induced termination of obligate diapause of mink (Mustela vison) blastocysts in vitro and subsequent establishment of embryonic stem-like cells. J Reprod Fertil. 109(2):229-236.
    Poueymirou WT, Auerbach W, Frendewey D, Hickey JF, Escaravage JM, Esau L, DoréAT, Stevens S, Adams NC, Dominguez MG, Gale NW, Yancopoulos GD, DeChiara TM, Valenzuela DM. 2007. F0 generation mice fully derived from gene-targeted embryonic stem cells allowing immediate phenotypic analyses. Nat Biotechnol. 25(1):91-99.
    Prelle K, Vassiliev IM, Vassilieva SG, Wolf E, Wobus AM. 1999. Establishment of pluripotent cell lines from vertebrate species: present status and future prospects. Cells Tissues Organs 165: 220–236.
    Prowse AB, McQuade LR, Bryant KJ, Marcal H, Gray PP. 2007. Identification of potential pluripotency determinants for human embryonic stem cells following proteomic analysis of human and mouse fibroblast conditioned media. J Proteome Res. 6(9):3796-3807.
    Qi X, Li TG, Hao J, Hu J, Wang J, Simmons H, Miura S, Mishina Y, Zhao GQ. 2004. BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways. Proc Natl Acad Sci U S A. 101(16):6027-6032.
    Ramalho-Santos M, Yoon, S, Matsuzaki, Y, Mulligan, RC, Melton DA. 2002.‘Stemness’: transcriptional profiling of embryonic and adult stem cells. Science 298, 597–600.
    Resnick JL, Bixler LS, Cheng L, Donovan PJ. 1992. Long-term proliferation of mouse primordial germ cells in culture. Nature. 359(6395):550-551.
    Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A. 2000. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol. 18(4):399-404.
    Reubinoff BE, Pera MF, Vajta G, Trounson AO. 2001. Effective cryopreservation of human embryonic stem cells by the open pulled straw vitrification method. Hum Reprod. 16(10):2187-2194.
    Richards M, Fong CY, Chan WK, Wong PC, Bongso A. 2002. Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat Biotechnol. 20(9):933-936.
    Richards M, Tan S, Fong CY, Biswas A, Chan WK, Bongso A. 2003. Comparative evaluation of various human feeders for prolonged undifferentiated growth of human embryonic stem cells. Stem Cells. 21(5):546-556.
    Rideout WM 3rd, Hochedlinger K, Kyba M, Daley GQ, Jaenisch R. 2002. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell. 109(1):17-27.
    Robertson EJ, Evans MJ, Kaufman MH. 1983. X-chromosome instability in pluripotential stem cell lines derived from parthenogenetic embryos. J Embryol Exp Morphol. 74:297-309.
    Robertson EJ. 1983. Teratocarcinomas and embryonic stem cells: a practical approach. Oxford., IRL press.
    Robins A, Schulz. T 2004. Human Embryonic Stem Cell Protocols. Bresagen, Inc., Athen, GA.
    Rosner MH, Vigano MA, Ozato K, Timmons PM, Poirier F, Rigby PW, Staudt LM. 1990. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature.345(6277):686-692.
    Rossant J. 1976. Postimplantation development of blastomeres isolated from 4- and 8-cell mouse eggs. J Embryol Exp Morphol. 36(2):283-290.
    Saito S, Ugai H, Sawai K, Yamamoto Y, Minamihashi A, Kurosaka K, Kobayashi Y, Murata T, Obata Y, Yokoyama K. 2002. Isolation of embryonic stem-like cells from equine blastocysts and their differentiation in vitro. FEBS Lett. 531(3):389-396.
    Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH. 2004. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med. 10(1):55-63.
    Sato N, Sanjuan IM, Heke M, Uchida M, Naef F, Brivanlou AH. 2003. Molecular signature of human embryonic stem cells and its comparison with the mouse. Dev Biol. 260(2):404-413.
    Schenke-Layland K, Angelis E, Rhodes KE, Heydarkhan-Hagvall S, Mikkola HK, Maclellan WR. 2007.Collagen IV induces trophoectoderm differentiation of mouse embryonic stem cells. Stem Cells. 25(6):1529-1538.
    Schoonjans L, Albright GM, Li JL, Collen D, Moreadith RW. 1996. Pluripotential rabbitembryonic stem (ES) cells are capable of forming overt coat color chimeras following injection into blastocysts. Mol Reprod Dev 45: 439–443.
    Schoonjans L, Kreemers V, Danloy S, Moreadith RW, Laroche Y, Collen D. 2003. Improved generation of germline-competent embryonic stem cell lines from inbred mouse strains. Stem Cells. 21(1):90-97.
    Schramm RD, Paprocki AM. 2004. In vitro development and cell allocation following aggregation of split embryos with tetraploid or developmentally asynchronous blastomeres in rhesus monkeys. Cloning Stem Cells. 6(3):302-314.
    Shigenari A, Ando A, Baba T, Yamamoto T, Katsuoka Y, Inoko H. 1998. Characterization of alkaline phosphatase genes expressed in seminoma by cDNA cloning. Cancer Res. 15;58(22):5079-5082.
    Slayton WB, Spangrude GJ. 2004. Adult stem cells plasticity: In Adult stem cells. 1-18. Totowa, New Jersey: Humana press.
    Smith AG, Heath JK, Donaldson DD, Wong GG, Moreau J, Stahl M, Rogers D. 1988. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature. 336(6200):688-690.
    Smith AG. 2001. Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol. 17:435-462.
    Soares MJ, Wolfe MW. 2004. Human embryonic stem cells assemble and fulfill their developmental destiny. Endocrinology. 145(4):1514-1516.
    Staessen C, Platteau P, Van Assche E, Michiels A, Tournaye H, Camus M, Devroey P, Liebaers I, Van Steirteghem A. 2004. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod. 19(12):2849-2858.
    Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, K?ntgen F, Abbondanzo SJ. 1992. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature. 3;359(6390):76-79.
    Stojkovic M, Lako M, Stojkovic P, Stewart R, Przyborski S, Armstrong L, Evans J, Herbert M, Hyslop L, Ahmad S, Murdoch A, Strachan T. 2004. Derivation of human embryonic stem cells from day-8 blastocysts recovered after three-step in vitro culture. Stem Cells. 22(5):790-797.
    Strelchenko N, Verlinsky O, Kukharenko V, Verlinsky Y. 2004. Morula-derived human embryonic stem cells. Reprod Biomed Online. 9(6):623-629.
    Suemori H, Tada T, Torii R, Hosoi Y, Kobayashi K, Imahie H, Kondo Y, Iritani A, Nakatsuji N. 2001. Establishment of embryonic stem cell lines from cynomolgus monkey blastocysts produced by IVF or ICSI. Dev Dyn. 222(2):273-279.
    Suemori H. Establishment and therapeutic use of human embryonic stem cell lines. 2006. Hum Cell. 19(2):65-70.
    Sukoyan MA, Kerkis AY, Mello MR, Kerkis IE, Visintin JA, Pereira LV. 2002. Establishmentof new murine embryonic stem cell lines for the generation of mouse models of human genetic diseases. Braz J Med Biol Res. 35(5):535-542.
    Tabar NH. 2005. Isolation and differentiation of mouse embryonic stem cells. J. Reprod. Med. 3: 42-45.
    Tanaka N, Takeuchi T, Neri QV, Sills ES, Palermo GD. 2006. Laser-assisted blastocyst dissection and subsequent cultivation of embryonic stem cells in a serum/cell free culture system: applications and preliminary results in a murine model. J Transl Med. 4:20.
    Tao T, Niemann H. 2000. Cellular characterization of blastocysts derived from rabbit 4-, 8- and 16-cell embryos and isolated blastomeres cultured in vitro. Hum Reprod. 15(4):881-889.
    Tarkowski AK, Wróblewska J. 1967. Development of blastomeres of mouse eggs isolated at the 4- and 8-cell stage. J Embryol Exp Morphol. 18(1):155-180.
    Tarkowski AK. 1959. Experimental studies on regulation in the development of isolated blastomeres of mouse eggs. Acta Theriol. 3, 191–267
    Tesar PJ. 2005. Derivation of germ-line-competent embryonic stem cell lines from preblastocyst mouse embryos. Proc Natl Acad Sci U S A. 102(23):8239-8244.
    Thompson JA, J Itskovitz-Eldor, SS Shapiro. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
    Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. 1998. Embryonic stem cell lines derived from human blastocysts. Science. 6;282(5391):1145-1147.
    Thomson JA, Kalishman J, Golos TG, Durning M, Harris CP, and Hearn JP. 1996. Pluripotent cell lines derived from common marmoset (Callithrix jacchus) blastocysts. Biol Reprod 55: 254-259.
    Thomson JA, Kalishman J, Golos TG, Durning M, Harris CP, Becker RA, Hearn JP. 1995. Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci U S A. 92(17):7844-78848.
    Toumadje A, Kusumoto K, Parton A, Mericko P, Dowell L, Ma G, Chen L, Barnes DW, Sato JD. 2003. Pluripotent differentiation in vitro of murine ES-D3 embryonic stem cells. In Vitro Cell Dev Biol Anim. 39(10):449-453.
    Toyooka Y, Tsunekawa N, Akasu R, Noce T. 2003. Embryonic stem cells can form germ cells in vitro. Proc Natl Acad Sci U S A. 100(20):11457-11462.
    Tsunoda Y, McLaren A. 1983. Effect of various procedures on the viability of mouse embryos containing half the normal number of blastomeres. J Reprod Fertil. 69(1):315-322.
    Varga AC, Wrana JL. 2005. The disparate role of BMP in stem cell biology. Oncogene. 24(37):5713-5721.
    Vassilieva S, Guan K, Pich U, and Wobus AM. 2000. Establishment of SSEA-1- and Oct-4-expressing rat embryonic stem-like cell lines and effects of cytokines of the IL-6 family on clonal growth. Exp Cell Res 258: 361–373.
    Vrana KE, Hipp JD, Goss AM, McCool BA, Riddle DR, Walker SJ, Wettstein PJ, Studer LP,Tabar V, Cunniff K, Chapman K, Vilner L, West MD, Grant KA, Cibelli JB. 2003. Nonhuman primate parthenogenetic stem cells. Proc Natl Acad Sci U S A. 100 Suppl 1:11911-11916.
    Wakayama S, Hikichi T, Suetsugu R, Sakaide Y, Bui HT, Mizutani E, Wakayama T. 2007. Efficient establishment of mouse embryonic stem cell lines from single blastomeres and polar bodies. Stem Cells. 25(4):986-93.
    Wakayama S, Ohta H, Kishigami S, Thuan NV, Hikichi T, Mizutani E, Miyake M, Wakayama T. 2005. Establishment of male and female nuclear transfer embryonic stem cell lines from different mouse strains and tissues. Biol Reprod. 72(4):932-936.
    Wang L, Duan E, Sung LY, Jeong BS, Yang X, Tian XC. 2005. Generation and characterization of pluripotent stem cells from cloned bovine embryos. Biol Reprod. 73(1):149-155.
    Wang Y, Chen S, Yang D, Le WD. 2007. Stem cell transplantation: a promising therapy for Parkinson's disease. J Neuroimmune Pharmacol. 2(3):243-250.
    Willadsen SM, Lehn-Jensen H, Fehilly CB, Newcomb R. 1981. The production of monozygotic twins of preselected parentage by micromanipulation of non-surgically collected cow embryos. Theriogenology. 15(1):23-29.
    Williams RL, Hilton DJ, Pease S, Willson TA, Stewart CL, Gearing DP, Wagner EF, Metcalf D, Nicola NA, Gough NM. 1988. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature. 336(6200):684-687.
    Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. 1997. Viable offspring derived from fetal and adult mammalian cells. Nature. 385(6619):810-813.
    Wilton LJ, Trounson AO. 1989 Biopsy of preimplantation mouse embryos: development of micromanipulated embryos and proliferation of single blastomeres in vitro. Biol Reprod. 40(1):145-52.
    Wobus AM, Boheler KR. 2005. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev. 85(2):635-678.
    Xu C, Inokuma MS, Denham J, Golds K, Kundu P, Gold JD, Carpenter MK. 2001. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol. 19(10):971-974.
    Xu C, Rosler E, Jiang J, Lebkowski JS, Gold JD, O'Sullivan C, Delavan-Boorsma K, Mok M, Bronstein A, Carpenter MK. 2005. Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium. Stem Cells. 23(3):315-323.
    Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T, Naito M, Nakao K, Nishikawa S. 2000. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature. 408(6808):92-96.
    Yates A, Chambers I. 2005. The homeodomain protein Nanog and pluripotency in mouse embryonic stem cells. Biochem Soc Trans. 33(Pt 6):1518-1521.
    Ying QL, Nichols J, Chambers I, Smith A. 2003. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell.115(3):281-292.
    Yoshida K, Taga T, Saito M, Suematsu S, Kumanogoh A, Tanaka T, Fujiwara H, Hirata M, Yamagami T, Nakahata T, Hirabayashi T, Yoneda Y, Tanaka K, Wang WZ, Mori C, Shiota K, Yoshida N, Kishimoto T. 1996. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci U S A. 93(1):407-411.
    Yu J, Thomson JA. 2007. Embryonic stem cells. [On-line] Available: http://stemcells.nih.gov/staticresources/info/scireport/PDF
    Zhang Q, Major MB, Takanashi S, Camp ND, Nishiya N, Peters EC, Ginsberg MH, Jian X, Randazzo PA, Schultz PG, Moon RT, Ding S. 2007. Small-molecule synergist of the Wnt/beta-catenin signaling pathway. Proc Natl Acad Sci U S A. 104(18):7444-7448.
    Zhang X, Ibrahimi OA, Olsen SK, Umemori H, Mohammadi M, Ornitz DM. 2006. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J Biol Chem. 281(23):15694-15700.
    Zwaka TP, Thomson JA. 2003. Homologous recombination in human embryonic stem cells. Nat Biotechnol. 21(3):319-321.
    Zwaka TP, Thomson JA. 2005. A germ cell origin of embryonic stem cells? Development. 132(2):227-233.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700